Number of the records: 1
Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue
- 1.
SYSNO ASEP 0481666 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue Author(s) Studenovský, Martin (UMCH-V) RID, ORCID
Sivák, Ladislav (MBU-M) RID
Sedláček, Ondřej (UMCH-V) RID, ORCID
Konefal, Rafal (UMCH-V) RID, ORCID
Horková, Veronika (MBU-M)
Etrych, Tomáš (UMCH-V) RID, ORCID
Kovář, Marek (MBU-M) RID, ORCID
Říhová, Blanka (MBU-M) RID
Šírová, Milada (MBU-M) RID, ORCIDSource Title Journal of Controlled Release. - : Elsevier - ISSN 0168-3659
Roč. 269, 10 January (2018), s. 214-224Number of pages 11 s. Language eng - English Country NL - Netherlands Keywords enhanced permeability and retention effect ; nitric oxide donor ; polymer-based cytotoxic drugs Subject RIV CD - Macromolecular Chemistry OECD category Polymer science Subject RIV - cooperation Institute of Microbiology - Microbiology, Virology R&D Projects GA14-12742S GA ČR - Czech Science Foundation (CSF) NV16-28600A GA MZd - Ministry of Health (MZ) LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Institutional support UMCH-V - RVO:61389013 ; MBU-M - RVO:61388971 UT WOS 000423760400019 EID SCOPUS 85034437726 DOI 10.1016/j.jconrel.2017.11.017 Annotation The delivery of nitric oxide (NO) specifically to solid tumours was explored in this study as a strategy to augment the passive accumulation of nanomedicines in tumours induced by the Enhanced Permeability and Retention (EPR) effect. An increase in accumulation was achieved by the binding of the chemical precursor of NO, based on an organic nitrate, to a water-soluble synthetic polymer drug carrier. Four structurally different N-(2-hydroxypropyl)methacrylamide (HPMA)-based polymer NO donors were synthesized. Depending on their chemical structure, two of these donors were hydrolytically stable, while two rapidly released the parent nitrate under acidic conditions, mimicking the intracellular environment. The polymer NO donors were shown to overcome the drawbacks related to low-molecular-weight NO releasing compounds, namely systemic toxicity, lack of site specificity, and fast blood clearance. The NO donors showed intracellular NO release upon incubation with tumour cells. In vivo, they potentiated the EPR effect, resulting in an increased accumulation of polymer-bound cytotoxic drug doxorubicin (Dox) in EL4 T-cell lymphoma inoculated in mice. This led to a better therapeutic outcome in the treatment of lymphoma with the high-molecular-weight polymer conjugates carrying Dox but not in the treatment with the free Dox. The localized augmentation of the EPR effect via the tumour-specific NO delivery system can be viewed as a promising strategy to potentiate polymer-based tumour therapy without increasing systemic toxicity. Workplace Institute of Macromolecular Chemistry Contact Eva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358 Year of Publishing 2019
Number of the records: 1